Baldwin Investment Management, LLC Edwards Lifesciences Corp Transaction History

Baldwin Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$84.3 - $94.31 $50,580 - $56,586	-600 Reduced 20.36%	2,347 $216,000
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $7,834 - $10,320	-108 Reduced 3.54%	2,947 $281,000
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $3,085 - $3,888	-50 Reduced 1.61%	3,055 $232,000
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $6,928 - $9,338	-100 Reduced 3.12%	3,105 $215,000
Q2 2023 Aug 01, 2023	SELL	$81.41 - $94.33 $48,846 - $56,598	-600 Reduced 15.77%	3,205 $302,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $21,164 - $24,085	-285 Reduced 6.97%	3,805 $314,000
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $23,905 - $30,604	350 Added 9.36%	4,090 $305,000
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $20,582 - $24,550	-200 Reduced 5.08%	3,740 $423,000
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $8,384 - $10,476	-100 Reduced 2.48%	3,940 $408,000
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $271,447 - $353,257	4,040 New	4,040 $322,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Baldwin Investment Management, LLC with notifications on news.